Advertisement

Non-infectious Problems

  • Joseph Torresi
  • Sarah McGuinness
  • Karin Leder
  • Daniel O’Brien
  • Tilman Ruff
  • Mike Starr
  • Katherine Gibney
Chapter
  • 239 Downloads

Abstract

Five non-infectious problems of travel are set out in this chapter. Not all of them need to be discussed with every traveller, but travel medicine practitioners need to be well acquainted with each. Section 6.1, Fitness to Fly, summarises some hazards of and contraindications to air travel. This section is relevant for travellers with special needs. Section 6.2, Motion Sickness, provides the necessary information to advise travellers who seek help with this sometimes distressing problem. Jet lag (Sect. 6.3) is a problem for many who cross several time zones and is worth discussing with those involved in important activities where alertness and a high level of functioning are crucial within the first few days after arrival. Venous thromboembolism (Sect. 6.4) should be discussed with all travellers who may be at increased risk. Altitude illness (Sect. 6.5) should be discussed with all travellers going to altitudes higher than 2500 m, and the table of altitudes of various destinations in this chapter can be useful.

References

  1. 1.
    Mieske K, Flaherty G, O’Brien T. Journeys to high altitude—risks and recommendations for travellers. J Travel Med. 2010;17(1):48–62.CrossRefGoogle Scholar
  2. 2.
    Luks AM, McIntosh SE, et al. Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness: 2014 update. Wilderness Environ Med. 2014;25:S4–S14.CrossRefGoogle Scholar

Key Reading

    Fitness to Fly

    1. Hu X, Cowl CT, Baqir M, Ryu JH. Air travel and pneumothorax. Chest. 2014;145:688–94.CrossRefGoogle Scholar
    2. Humphreys S, Deyermond R, Bali I, Stevenson M, Fee JP. The effect of high altitude commercial air travel on oxygen saturation. Anaesthesia. 2005;60(5):458–60.CrossRefGoogle Scholar
    3. Muhm JM, Rock PB, McMullin DL, et al. Effect of aircraft-cabin altitude on passenger discomfort. N Engl J Med. 2007;357:18–27.CrossRefGoogle Scholar
    4. Nable JV, Tupe CL, Gehle BD, Brady WJ. In-flight medical emergencies during commercial travel. N Engl J Med. 2015;373:939–45.CrossRefGoogle Scholar
    5. Sheffield PJ. Flying after diving guidelines: a review. Aviat Space Environ Med. 1990;61:1130–8.PubMedGoogle Scholar

    Motion Sickness

    1. Brainard A, Gresham C. Prevention and treatment of motion sickness. Am Fam Physician. 2014;90(1):41–6.PubMedGoogle Scholar
    2. eTG Complete [Internet]. Melbourne (VIC). Therapeutic guidelines limited, 2017. Neurology expert group: motion sickness. (eTG July 2018 edition). 2018. https://tgldcdp.tg.org.au/etgcomplete. Accessed 12/12/2018.
    3. Golding JF, Gresty MA. Pathophysiology and treatment of motion sickness. Curr Opin Neurol. 2015;28(1):83–8.CrossRefGoogle Scholar
    4. Graudins LV. Preventing motion sickness in children. Aust Prescr. 2009;32:61–3. https://www.nps.org.au/australian-prescriber/articles/preventing-motion-sickness-in-children. Accessed 12/12/2018.CrossRefGoogle Scholar
    5. Murdin L, Golding J, Bronstein A. Managing motion sickness. BMJ. 2011;343:d7430.CrossRefGoogle Scholar
    6. Wilson N. Sea sickness: cruising towards a healthy holiday. Aust J Pharm. 2017;98(1161):81–3.Google Scholar

    Jet Lag

    1. Brzezinski A. Melatonin in humans. N Engl J Med. 1997;336(3):186–95.CrossRefGoogle Scholar
    2. Brown GM, et al. Melatonin and its relevance to jet lag. Travel Med Infect Dis. 2009;7:69–81.CrossRefGoogle Scholar
    3. Herxheimer A. Jet lag. BMJ Clin Evid. 2014;4:2303.Google Scholar
    4. Sack RL. Clinical practice. Jet lag. N Engl J Med. 2010;362(5):440–7.CrossRefGoogle Scholar
    5. Suhner A, Schlagenhauf P, Tschopp A, Hauri-Bionda R, et al. Impact of melatonin on driving performance. J Travel Med. 1998;5:7–13.CrossRefGoogle Scholar

    Venous Thromboembolism

    1. Cesarone MR, Belcaro G, Nicolaides AN, Incandela L, et al. Venous thrombosis from air travel: the LONFLIT3 study. Prevention with aspirin vs low-molecular weight heparin (LMWH) in high-risk subjects: a randomised trial. Angiology. 2002;53(1):1–6.CrossRefGoogle Scholar
    2. Kelman CW, Kortt MA, Becker NG, Li Z, et al. Deep vein thrombosis and air travel: record linkage study. BMJ. 2003;327(7423):1072.CrossRefGoogle Scholar
    3. Lapostolle F, Surget V, Borron SW, Desmaizieres M, et al. Severe pulmonary embolism associated with air travel. N Engl J Med. 2001;345(11):779–83.CrossRefGoogle Scholar
    4. Philbrick JT, Shumate R, Siadatay MS, Becker DM. Air travel and venous thromboembolism: a systematic review. J Gen Intern Med. 2007;22:107–14.CrossRefGoogle Scholar
    5. Ringwald J, et al. The place of new oral anticoagulants in travel medicine. Travel Med Infect Dis. 2014;12:7–19.CrossRefGoogle Scholar
    6. Sarvesvaran R. Sudden deaths associated with commercial air travel. Med Sci Law. 1986;26(1):35–8.CrossRefGoogle Scholar
    7. Schobersberger W. Traveller’s thrombosis: international consensus statement. Vasa. 2008;37:311–7.CrossRefGoogle Scholar
    8. Watson HG, Baglin TP. Guidelines on travel-related venous thrombosis. Br J Haematol. 2011;152(1):31–4.CrossRefGoogle Scholar

    Altitude Illness

    1. Bartsch P, Swenson ER. Clinical practice: acute high-altitude illnesses. N Engl J Med. 2013;368(24):2294–302.CrossRefGoogle Scholar
    2. Hacket PH, Gallagher SA. High altitude disease: unique pediatric considerations. In Wiley JF (Ed.), UpToDate. 2019; retrieved 30 May 2019.Google Scholar
    3. Hackett PH, Shlim DR. Chapter 2: The pretravel consultation—altitude illness. In: Centers for Disease Control and Prevention Yellow Book 2018: Health Information for International Travel. New York: Oxford University Press; 2017. https://wwwnc.cdc.gov/travel/yellowbook/2018/the-pre-travel-consultation/altitude-illness. Accessed 24 Dec 2018.
    4. Kelly TE, Hackett PH. Acetazolamide and sulfonamide allergy: a not so simple story. High Alt Med Biol. 2010;11(4):319–23.CrossRefGoogle Scholar
    5. Lawrence JS, Reid ST. Risk determinants of Acute Mountain Sickness and Summit Success on a 6-day ascent of Mount Kilimanjaro (5895 m). Wilderness Environ Med. 2015;27(1):78–84.CrossRefGoogle Scholar
    6. Luks AM. Physiology in Medicine: a physiologic approach to prevention and treatment of acute high-altitude illnesses. J Appl Physiol. 2015;118:509–19.CrossRefGoogle Scholar
    7. Netzer N, Strohl K, et al. Hypoxia-related altitude illnesses. J Travel Med. 2013;20(4):247–55.CrossRefGoogle Scholar
    8. Parise I. Travelling safely to places at high altitude—understanding and preventing altitude illness. Aust Fam Physician. 2017;46(6):380–4.PubMedGoogle Scholar
    9. Pollard AJ, Murdoch DR, Bärtsch P. Children in the mountains. BMJ. 1998;316:874–5.CrossRefGoogle Scholar
    10. Pollard AJ, Niermeyer S, Barry P, et al. Children at High Altitude: an international consensus statement by an ad hoc committee of the International Society for Mountain Medicine, March 12, 2001. High Alt Med Biol. 2001;2(3):389–403.CrossRefGoogle Scholar
    11. Yaron M, Niermeyer S. Travel to high altitude with young children: an approach for clinicians. High Alt Med Biol. 2008;9(4):265–9.CrossRefGoogle Scholar
    12. Zafren K. Prevention of high altitude illness. Travel Med Infect Dis. 2014;12(1):29–39.CrossRefGoogle Scholar

    Altitude Illness: Resources for Patients

    1. CDC Traveler’s Health—Travel to High Altitudes (US). https://wwwnc.cdc.gov/travel/page/travel-to-high-altitudes.
    2. International Society for Mountain Medicine (ISMM) Public Resources. http://ismm.org/category/article/public/.

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Joseph Torresi
    • 1
    • 2
    • 3
    • 4
  • Sarah McGuinness
    • 5
    • 6
  • Karin Leder
    • 7
    • 8
  • Daniel O’Brien
    • 9
    • 10
  • Tilman Ruff
    • 11
    • 12
  • Mike Starr
    • 13
  • Katherine Gibney
    • 14
  1. 1.Professor of Medicine, Infectious Diseases Physician University of Melbourne, Department of Microbiology and ImmunologyThe Peter Doherty Institute for Infection and Immunity, The University of MelbourneMelbourneAustralia
  2. 2.Knox Private HospitalMelbourneAustralia
  3. 3.Epworth Eastern HospitalMelbourneAustralia
  4. 4.Austin HospitalMelbourneAustralia
  5. 5.Infectious Diseases Physician, Department of Infectious DiseasesThe Alfred Hospital and Monash UniversityMelbourneAustralia
  6. 6.Lecturer, Infectious Disease Epidemiology UnitSchool of Public Health and Preventive Medicine, Monash UniversityMelbourneAustralia
  7. 7.Professor of Medicine, Infectious Diseases Physician, Head of Infectious Disease EpidemiologySchool of Public Health and Preventive Medicine, Monash UniversityMelbourneAustralia
  8. 8.Head of Travel Medicine and Immigrant Health, Victorian Infectious Disease ServiceRoyal Melbourne Hospital Peter Doherty, Institute for Infection and ImmunityMelbourneAustralia
  9. 9.Associate Professor, Victorian Infectious Diseases ServiceRoyal Melbourne HospitalMelbourneAustralia
  10. 10.Department of Infectious DiseasesUniversity Hospital GeelongGeelongAustralia
  11. 11.Associate Professor, Nossal Institute for Global HealthSchool of Population and Global Health, The University of MelbourneMelbourneAustralia
  12. 12.International Medical Advisor, Australian Red Cross (1996–2019)Founding Head of Travel Medicine at Fairfield and Royal Melbourne HospitalsMelbourneAustralia
  13. 13.Paediatrician, Infectious Diseases Physician, Consultant in Emergency Medicine, Director of Paediatric Education, Royal Children’s Hospital Melbourne, Honorary Clinical Associate Professor, University of MelbourneMelbourneAustralia
  14. 14.Infectious Diseases Physician, Public Health Physician and Senior Research FellowThe Austin Hospital, The Royal Melbourne Hospital, and The University of Melbourne, at The Peter Doherty Institute for Infection and ImmunityMelbourneAustralia

Personalised recommendations